Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Twist Bioscience Corp

NASDAQ: TWST · Life Sciences · 17 alerts · CIK 1581280

Share price
$105.04Close, Nov 16
Market cap
$7.16B
Shares outstanding
68.18MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Twist Bioscience Corp filings on SEC EDGAR ↗

4:06 PM ET Form 4
Insider Selling

Twist Bioscience Insider Dennis Cho Sells $128K of Stock

Dennis Cho sold 949 shares of Twist Bioscience Corp at $135.40 a share, worth $128K in total on Nov 3, 2026. Shares held after the trade: 62,840 (-1.5%).

Value
$128K
Shares
949
Price
$135.40
Holding change
-1.5%
Trade date
Nov 3, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience SVP of Human Resources Paula Green Sells $136K of Stock

Paula Green, SVP of Human Resources, sold 1,007 shares of Twist Bioscience Corp at $135.40 a share, worth $136K in total on Nov 3, 2026. Shares held after the trade: 105,625 (-0.9%).

Value
$136K
Shares
1,007
Price
$135.40
Role
SVP of Human Resources
Holding change
-0.9%
Trade date
Nov 3, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CEO Emily M. Leproust Sells $619K of Stock

Emily M. Leproust, CEO, sold 4,573 shares of Twist Bioscience Corp at $135.40 a share, worth $619K in total on Nov 3, 2026. Shares held after the trade: 558,187 (-0.8%).

Value
$619K
Shares
4,573
Price
$135.40
Role
CEO
Holding change
-0.8%
Trade date
Nov 3, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CAO Robert F. Werner Sells $20K of Stock

Robert F. Werner, CAO, sold 148 shares of Twist Bioscience Corp at $135.40 a share, worth $20K in total on Nov 3, 2026. Shares held after the trade: 42,769 (-0.3%).

Value
$20K
Shares
148
Price
$135.40
Role
CAO
Holding change
-0.3%
Trade date
Nov 3, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience President and COO Patrick John Finn Sells $347K of Stock

Patrick John Finn, President and COO, sold 2,565 shares of Twist Bioscience Corp at $135.40 a share, worth $347K in total on Nov 3, 2026. Shares held after the trade: 180,278 (-1.4%).

Value
$347K
Shares
2,565
Price
$135.40
Role
President and COO
Holding change
-1.4%
Trade date
Nov 3, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience President and COO Patrick John Finn Sells $302K of Stock

Patrick John Finn, President and COO, sold 2,245 shares of Twist Bioscience Corp at $134.59 a share, worth $302K in total on Oct 23, 2026. Shares held after the trade: 182,843 (-1.2%).

Value
$302K
Shares
2,245
Price
$134.59
Role
President and COO
Holding change
-1.2%
Trade date
Oct 23, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CFO Adam Laponis Sells $385K of Stock

Adam Laponis, CFO, sold 2,462 shares of Twist Bioscience Corp at $156.30 a share, worth $385K in total on Oct 9, 2026. Shares held after the trade: 98,114 (-2.4%).

Value
$385K
Shares
2,462
Price
$156.30
Role
CFO
Holding change
-2.4%
Trade date
Oct 9, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CEO Emily M. Leproust Sells $910K of Stock

Emily M. Leproust, CEO, sold 4,503 shares of Twist Bioscience Corp at $200.44 to $206.84 a share (average $202.10) in 7 transactions, worth $910K in total on Oct 5, 2026. Shares held after the trade: 562,805 (-0.0%).

Value
$910K
Shares
4,503
Average price
$202.10
Role
CEO
Holding change
-0.0%
Trade date
Oct 5, 2026
4:06 PM ET Form 4
Insider Selling

Twist Bioscience CFO Adam Laponis Sells $1.52M of Stock

Adam Laponis, CFO, sold 8,057 shares of Twist Bioscience Corp at $188.88 a share, worth $1.52M in total on Oct 2, 2026. Shares held after the trade: 100,576 (-7.4%).

Value
$1.52M
Shares
8,057
Price
$188.88
Role
CFO
Holding change
-7.4%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CEO Emily M. Leproust Sells $8.77M of Stock

Emily M. Leproust, CEO, sold 46,391 shares of Twist Bioscience Corp at $188.88 to $200.00 a share (average $189.04) in 2 transactions, worth $8.77M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 567,308 (-7.5%).

Value
$8.77M
Shares
46,391
Average price
$189.04
Role
CEO
Holding change
-7.5%
Trade date
Oct 1, 2026 to Oct 2, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience President and COO Patrick John Finn Sells $4.86M of Stock

Patrick John Finn, President and COO, sold 25,714 shares of Twist Bioscience Corp at $188.88 a share, worth $4.86M in total on Oct 2, 2026. Shares held after the trade: 185,088 (-12.2%).

Value
$4.86M
Shares
25,714
Price
$188.88
Role
President and COO
Holding change
-12.2%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience SVP of Human Resources Paula Green Sells $1.91M of Stock

Paula Green, SVP of Human Resources, sold 10,088 shares of Twist Bioscience Corp at $188.88 a share, worth $1.91M in total on Oct 2, 2026. Shares held after the trade: 106,632 (-8.6%).

Value
$1.91M
Shares
10,088
Price
$188.88
Role
SVP of Human Resources
Holding change
-8.6%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience Insider Dennis Cho Sells $1.8M of Stock

Dennis Cho sold 9,514 shares of Twist Bioscience Corp at $188.88 a share, worth $1.8M in total on Oct 2, 2026. Shares held after the trade: 63,789 (-13.0%).

Value
$1.8M
Shares
9,514
Price
$188.88
Holding change
-13.0%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CAO Robert F. Werner Sells $280K of Stock

Robert F. Werner, CAO, sold 1,482 shares of Twist Bioscience Corp at $188.88 a share, worth $280K in total on Oct 2, 2026. Shares held after the trade: 42,917 (-3.3%).

Value
$280K
Shares
1,482
Price
$188.88
Role
CAO
Holding change
-3.3%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling

Twist Bioscience CEO Emily M. Leproust Sells $56.3M of Stock

Emily M. Leproust, CEO, sold 356,546 shares of Twist Bioscience Corp at $151.46 to $163.39 a share (average $157.99) in 13 transactions, worth $56.3M in total on Sep 17, 2026. Shares held after the trade: 673,569 (-25.6%).

Value
$56.3M
Shares
356,546
Average price
$157.99
Role
CEO
Holding change
-25.6%
Trade date
Sep 17, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.